Answers are grounded in this paper and cite their sources.
The BRPF (Bromodomain and PHD Finger-containing) protein family are important scaffolding proteins for assembly of MYST histone acetyltransferase complexes. A selective benzimidazolone BRPF1 inhibitor showing micromolar activity in a cellular target engagement assay was recently described. Herein, we report the optimization of this series leading to the identification of a superior BRPF1 inhibitor suitable for in vivo studies.
No takes yet. Share an insight, caveat, or question.
Bamborough et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: